$CME
CME Group Inc. · NasdaqGS · Financial Services
- Market cap
- 109.42B
- Volume
- 2.18M
- P/E
- 25.06
- Day range
- 303.93 – 307.78
- 52w range
- 218.31 – 329.16
- Analyst target
- 316.00
AI Summary
Generating a unique summary for CME…
AI-generated for information only — not investment advice.
Share this ticker
$CME -0.09% at 305.71 Ray Dalio and 0 other tracked billionaires hold it. https://billionairestrading.com/stocks/CME
Company summary
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. CME Group Inc. partners with FutureSports to futures on sports indexes. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
Institutional ownership
Institutions hold 91.51% · insiders 0.44% · 2,342 institutions
| Holder | Shares | Value | % held | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 30.57M | $9.34B | 8.50% | 2026-06-30 |
| Vanguard Capital Management LLC | 23.66M | $7.23B | 6.58% | 2026-06-30 |
| State Street Corporation | 16.35M | $5.00B | 4.55% | 2026-06-30 |
| Morgan Stanley | 9.73M | $2.97B | 2.71% | 2026-06-30 |
| Geode Capital Management, LLC | 9.27M | $2.83B | 2.58% | 2026-06-30 |
| Vanguard Portfolio Management LLC | 9.17M | $2.80B | 2.55% | 2026-06-30 |
| Capital World Investors | 6.82M | $2.09B | 1.90% | 2026-06-30 |
| JPMORGAN CHASE & CO | 5.77M | $1.76B | 1.60% | 2026-06-30 |
| Sanders Capital, LLC | 5.07M | $1.55B | 1.41% | 2026-06-30 |
| NORGES BANK | 4.82M | $1.47B | 1.34% | 2026-06-30 |
Hedge fund & billionaire activity
Insider transactions
| Insider | Role | Transaction | Shares | Date |
|---|---|---|---|---|
| GEPSMAN MARTIN J | Director | Sale at price 302.50 per share. | 400.00 | 2026-10-22 |
| SHEPARD WILLIAM R | Director | Purchase at price 268.76 per share. | 292.00 | 2026-09-25 |
| SAMMANN DEREK LOUIS | Officer | Stock Award(Grant) at price 275.09 per share. | 2.9K | 2026-09-15 |
| VROMAN KENDAL L | Officer | Stock Award(Grant) at price 275.09 per share. | 2.6K | 2026-09-15 |
| COOK ELIZABETH A | Director | Sale at price 280.11 per share. | 500.00 | 2026-09-14 |
| DUFFY TERRENCE A | Chief Executive Officer | Sale at price 274.41 - 275.03 per share. | 15.0K | 2026-09-10 |
| BENESH KATHRYN | Director | Stock Award(Grant) at price 225.00 per share. | 645.00 | 2026-06-25 |
| MALONEY PATRICK W | Director | Stock Award(Grant) at price 225.00 per share. | 645.00 | 2026-06-25 |
| SEIFU RAHAEL | Director | Stock Award(Grant) at price 225.00 per share. | 645.00 | 2026-06-25 |
| KAYE DANIEL G | Director | Stock Award(Grant) at price 225.00 per share. | 645.00 | 2026-06-25 |
| LOCKETT PHYLLIS M | Director | Stock Award(Grant) at price 225.00 per share. | 645.00 | 2026-06-25 |
| FORD HAROLD EUGENE JR | Director | Stock Award(Grant) at price 225.00 per share. | 1.1K | 2026-06-25 |
Analyst ratings
Consensus score 2.41 (1 = strong buy, 5 = sell) · mean target 316.00
- UBSNeutralmain2026-10-22
- Morgan StanleyOverweightmain2026-10-22
- BarclaysEqual-Weightmain2026-10-22
- Wells FargoOverweightmain2026-10-22
- Piper SandlerOverweightreit2026-10-22
- JP MorganOverweightup2026-10-22
- Wells FargoOverweightmain2026-10-14
- Morgan StanleyOverweightmain2026-10-09
- BarclaysEqual-Weightmain2026-10-07
- UBSNeutralmain2026-10-05
Earnings
Next report: 2026-10-21
| Quarter | EPS actual | EPS estimate | Surprise |
|---|---|---|---|
| 4Q2025 | 2.77 | 2.74 | 0.03 |
| 1Q2026 | 3.36 | 3.37 | -0.01 |
| 2Q2026 | 2.99 | 2.91 | 0.08 |
| 3Q2026 | 3.02 | 2.99 | 0.03 |
SEC filings
- 10-QPeriodic Financial Reports2026-10-23Open
- 8-KCorporate Changes & Voting Matters2026-10-21Open
- 8-KCorporate Changes & Voting Matters2026-09-25Open
- 8-KCorporate Changes & Voting Matters2026-09-09Open
- 8-KCorporate Changes & Voting Matters2026-08-11Open
- 10-QPeriodic Financial Reports2026-07-24Open
- 8-KCorporate Changes & Voting Matters2026-07-22Open
- 8-KCorporate Changes & Voting Matters2026-06-17Open
- 8-KCorporate Changes & Voting Matters2026-06-10Open
- DEFA14AProxy Statements2026-05-19Open
Latest CME news
- Bitcoin Cash vs Litecoin: Which Payment Coin Has More Upside in 2026?
CME futures launched, ETF filings hit the SEC, and two rival payment coins are pulling in opposite directions heading into year-end. One of them just made a 46% move in a single week, and the other can barely attract a dollar of ETF inflows.
Fri, 23 Oct 2026 23:40:25 +0000
- CME Crypto Derivatives Trading Volume Reaches $469.5B in Q3
CME Group’s (NASDAQ: $CME) crypto derivatives trading volume reached $469.5 billion in notional value during ...
Fri, 23 Oct 2026 16:30:00 +0000
- Financial Exchanges CME, Cboe, ICE, Nasdaq Benefiting From Sector Rotation Out Of AI Stocks
Financial exchanges CME stock, Cboe and ICE, along with Marex, Nasdaq and Tradeweb Markets, are benefiting from rotation out of AI stocks.
Thu, 22 Oct 2026 18:04:09 +0000
- CME Group (CME) Stock Climbs On Record Q3 Earnings And Margin Strength
CME Group came into this Q3 2026 earnings print with its stock already on a strong run, and buyers then pushed it another 3.6% higher intraday to about US$306. The headline story is simple: record third quarter revenue of US$1.7b and adjusted earnings per share of US$3.02 put fresh fuel under a futures and options powerhouse that was already priced for quality. The market is responding to volume and fee strength, not a turnaround. Average daily volume reached 29.4 million contracts, and...
Thu, 22 Oct 2026 16:13:22 +0000
- CME Q3 deep dive: diversified volume growth and product innovation underpin results
Financial derivatives exchange CME Group (NASDAQ:CME) announced better-than-expected revenue in Q3 2026, with sales up 13% year on year to $1.74 billion. Its non-GAAP profit of $3.02 per share was 1% above analysts’ consensus estimates.
Thu, 22 Oct 2026 09:34:27 +0000
- CME CEO Says Crypto Perps Are Swaps While Suing CFTC Over Their Approval
CME CEO Terry Duffy calls crypto perps swaps while CME sues the CFTC over their approval. Here is how the regulator answers.
Thu, 22 Oct 2026 02:05:00 +0000
- CME Group: 3 Key Takeaways for Long-Term Investors
Market data has now grown for 34 straight quarters, cementing a predictable revenue engine independent of trading swings.
Wed, 21 Oct 2026 18:34:02 +0000
- Kalshi Courts Wall Street in Bid to Be the ‘Inflation Exchange’
Kalshi Inc. is opening up a new frontier in its rivalry with traditional financial exchanges by pitching the world’s largest banks and hedge funds on a futures market tied to US inflation.
Fri, 23 Oct 2026 13:00:03 +0000